Clinical risk factors for admission with Pseudomonas and multidrug-resistant Pseudomonas community-acquired pneumonia

被引：0
|
作者：
Adeniyi J. Idigo
J. Michael Wells
Matthew L. Brown
Howard W. Wiener
Russell L. Griffin
Gary Cutter
Sadeep Shrestha
Rachael A. Lee
机构：
[1] University of Alabama at Birmingham,Department of Epidemiology, School of Public Health
[2] University of Alabama at Birmingham,Division of Pulmonary, Allergy, and Critical Care Medicine
[3] University of Alabama at Birmingham Lung Health Center,Department of Pharmacy
[4] Birmingham VA Medical Center,Department of Biostatistics, School of Public Health
[5] University of Alabama at Birmingham Hospital,Division of Infectious Diseases
[6] University of Alabama at Birmingham,undefined
[7] University of Alabama at Birmingham School of Medicine,undefined
来源：
Antimicrobial Resistance & Infection Control | / 11卷
关键词：
Community-acquired pneumonia; Multidrug-resistant ; Chronic obstructive pulmonary disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Risk factors for complicated community-acquired pneumonia in children
    Tugcu, Gokcen Dilsa
    Ozsezen, Beste
    Turkyilmaz, Irem
    Zorlu, Betul Pehlivan
    Polat, Sanem Eryilmaz
    Parlakay, Aslinur Ozkaya
    Cinel, Guzin
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [22] A score to predict Pseudomonas aeruginosa infection in older patients with community-acquired pneumonia
    Kingkarn Wijit
    Paveena Sonthisombat
    Jaruwan Diewsurin
    BMC Infectious Diseases, 23
  • [23] A score to predict Pseudomonas aeruginosa infection in older patients with community-acquired pneumonia
    Wijit, Kingkarn
    Sonthisombat, Paveena
    Diewsurin, Jaruwan
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [24] Impact of Pseudomonas aeruginosa coverage on the prognosis of elderly patients with community-acquired pneumonia
    Goto, Akihiko
    Komiya, Kosaku
    Umeki, Kenji
    Hiramatsu, Kazufumi
    Kadota, Jun-ichi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (01) : 55 - 60
  • [25] Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors
    von Baum, H.
    Welte, T.
    Marre, R.
    Suttorp, N.
    Ewig, S.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (03) : 598 - 605
  • [26] Clinical characteristics and risk factors for mortality in patients with community-acquired staphylococcal pneumonia
    Thabet, Nancy
    Shindo, Yuichiro
    Okumura, Junya
    Sano, Masahiro
    Sakakibara, Toshihiro
    Murakami, Yasushi
    Kobayashi, Hironori
    Saka, Hideo
    Kondo, Masashi
    Hasegawa, Yoshinori
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2022, 84 (02): : 247 - 259
  • [27] Risk Factors Associated with Potentially Antibiotic-Resistant Pathogens in Community-Acquired Pneumonia
    Prina, Elena
    Ranzani, Otavio T.
    Polverino, Eva
    Cilloniz, Catia
    Ferrer, Miquel
    Fernandez, Laia
    Puig de la Bellacasa, Jorge
    Menendez, Rosario
    Mensa, Josep
    Torres, Antoni
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2015, 12 (02) : 153 - 160
  • [28] Community-Acquired Pneumonia with Risk for Drug-Resistant Pathogens
    Fleming, Virginia
    Buck, Brian
    Nix, Nancy
    Kumar, Parag
    Southwood, Robin
    SOUTHERN MEDICAL JOURNAL, 2013, 106 (03) : 209 - 216
  • [29] Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community
    Farr, BM
    Woodhead, MA
    Macfarlane, JT
    Bartlett, CLR
    McCracken, JS
    Wadsworth, J
    Miller, DL
    RESPIRATORY MEDICINE, 2000, 94 (05) : 422 - 427
  • [30] Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
    Coyne, Ashlan J. Kunz
    El Ghali, Amer
    Holger, Dana
    Rebold, Nicholas
    Rybak, Michael J.
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (02) : 661 - 682
12345